malondialdehyde has been researched along with ramipril in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (69.23) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blazícek, P; Dzúrik, R; Gazdíková, K; Heidland, A; Schinzel, R; Sebeková, K; Spustová, V; Syrová, D | 1 |
| Akula, A; Kota, MK; Routhu, KV; Veeravalli, KK | 1 |
| Ahn, JY; Han, SH; Jin, DK; Kim, DS; Kim, HS; Koh, KK; Quon, MJ; Shin, EK | 1 |
| Gottsäter, A; Ohlin, AK; Ohlin, H; Tingberg, E | 1 |
| Kumar, VK; Rao, PR; Subbaraju, GV; Viswanath, RK | 1 |
| Baráth, A; Bereczki, C; Gellén, B; Haszon, I; Monostori, P; Németh, I; Túri, S | 1 |
| Ahn, JY; Han, SH; Koh, KK; Lee, Y; Quon, MJ; Shin, EK | 1 |
| Choi, YB; Kim, JS; Kim, YI; Lee, KS; Yun, I | 1 |
| Couture, R; de Champlain, J; El Midaoui, A; Fantus, IG; Ismael, MA; Lu, H | 1 |
| Akinmoladun, AC; Barthwal, MK; Dikshit, M; Farombi, EO; Obuotor, EM | 1 |
| Arora, D; Garg, GR; Halder, S; Khanna, N; Mahajan, P; Mehta, AK; Sharma, SB | 1 |
| Chan, WP; Chirkov, YY; Heresztyn, T; Horowitz, JD; Leslie, S; Liberts, EA; Procter, N; Rajendran, S; Willoughby, SR | 1 |
| Akhtar, M; Akhtar, MS; Ali, J; Ansari, SH; Hassan, Q; Najmi, AK; Pillai, KK | 1 |
5 trial(s) available for malondialdehyde and ramipril
| Article | Year |
|---|---|
Vascular and metabolic effects of combined therapy with ramipril and simvastatin in patients with type 2 diabetes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; C-Reactive Protein; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin Resistance; Lipids; Malondialdehyde; Ramipril; Simvastatin; Vasodilation | 2005 |
Lipid peroxidation is not increased in heart failure patients on modern pharmacological therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Captopril; Comorbidity; Delayed-Action Preparations; Dinoprost; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Lipid Peroxidation; Losartan; Male; Malondialdehyde; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Nitric Oxide Donors; Oxidative Stress; Ramipril; Stroke Volume; Ultrasonography; Ventricular Dysfunction, Left | 2006 |
Different pathomechanisms of essential and obesity-associated hypertension in adolescents.
Topics: Adolescent; Angiotensin-Converting Enzyme Inhibitors; Body Mass Index; Endothelin-1; Female; Humans; Hypertension; Leptin; Male; Malondialdehyde; Nitric Oxide; Obesity; Peptidyl-Dipeptidase A; Ramipril; Xanthine Oxidase | 2006 |
Combined therapy with ramipril and simvastatin has beneficial additive effects on tissue factor activity and prothrombin fragment 1+2 in patients with type 2 diabetes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; C-Reactive Protein; Cross-Over Studies; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Hemostasis; Humans; Hypercholesterolemia; Male; Malondialdehyde; Middle Aged; Peptide Fragments; Prothrombin; Ramipril; Simvastatin; Thromboplastin | 2007 |
Ramipril sensitizes platelets to nitric oxide: implications for therapy in high-risk patients.
Topics: Adenosine Diphosphate; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Arginine; Biomarkers; Blood Platelets; Cohort Studies; Cyclic GMP; Double-Blind Method; Drug Administration Schedule; Female; Guanylate Cyclase; Humans; Male; Malondialdehyde; Middle Aged; Nitric Oxide; Nitroprusside; Oxidative Stress; Platelet Aggregation; Ramipril; Thrombospondin 1 | 2012 |
8 other study(ies) available for malondialdehyde and ramipril
| Article | Year |
|---|---|
Effects of ramipril in nondiabetic nephropathy: improved parameters of oxidatives stress and potential modulation of advanced glycation end products.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Blood Glucose; Blood Pressure; Creatinine; Cystatin C; Cystatins; Diabetic Nephropathies; Female; Glomerulonephritis; Glycation End Products, Advanced; Homocysteine; Humans; Lipofuscin; Lysine; Male; Malondialdehyde; Middle Aged; Nephritis, Interstitial; Oxidative Stress; Polycystic Kidney Diseases; Ramipril; Severity of Illness Index; Statistics as Topic; Treatment Outcome | 2003 |
Infarct size limiting effect of apstatin alone and in combination with enalapril, lisinopril and ramipril in rats with experimental myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Bradykinin Receptor Antagonists; Drug Therapy, Combination; Enalapril; Female; Heart Rate; Lipid Peroxides; Lisinopril; Male; Malondialdehyde; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Peptides; Ramipril; Rats; Rats, Sprague-Dawley; Time Factors | 2003 |
Cardioprotective activity of alcoholic extract of Tinospora cordifolia in ischemia-reperfusion induced myocardial infarction in rats.
Topics: Alcohols; Animals; Antihypertensive Agents; Cardiotonic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Heart Rate; Intubation, Gastrointestinal; Male; Malondialdehyde; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Plant Extracts; Ramipril; Rats; Rats, Sprague-Dawley; Tinospora | 2005 |
Ramipril protects from free radical induced white matter damage in chronic hypoperfusion in the rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Brain Injuries; Brain Ischemia; Chronic Disease; Disease Models, Animal; Free Radicals; Glutathione; Glutathione Disulfide; Malondialdehyde; Neuroglia; Ramipril; Rats; Rats, Sprague-Dawley | 2008 |
Comparative effects of N-acetyl-L-cysteine and ramipril on arterial hypertension, insulin resistance, and oxidative stress in chronically glucose-fed rats.
Topics: Acetylcysteine; Aldehydes; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Blood Pressure; Diet; Free Radical Scavengers; Glucose; Hypertension; Insulin Receptor Substrate Proteins; Insulin Resistance; Lipid Peroxidation; Liver; Male; Malondialdehyde; Muscle, Skeletal; NADPH Oxidases; Oxidative Stress; Oxygen Consumption; Ramipril; Rats; Rats, Wistar | 2008 |
Ramipril-like activity of Spondias mombin linn against no-flow ischemia and isoproterenol-induced cardiotoxicity in rat heart.
Topics: Anacardiaceae; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Agents; Catalase; Cholesterol; Disease Models, Animal; Dose-Response Relationship, Drug; Glutathione; Isoproterenol; L-Lactate Dehydrogenase; Male; Malondialdehyde; Myocardial Infarction; Myocardial Ischemia; Myocardium; Nitrites; No-Reflow Phenomenon; Phosphates; Plant Extracts; Plant Leaves; Ramipril; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Time Factors | 2010 |
Comparative effect of Ocimum sanctum, Commiphora mukul, folic acid and ramipril on lipid peroxidation in experimentally-induced hyperlipidemia.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Catalase; Cholesterol, Dietary; Cholesterol, HDL; Commiphora; Erythrocytes; Folic Acid; Hyperlipidemias; Lipid Peroxidation; Male; Malondialdehyde; Molecular Structure; Ocimum; Phytotherapy; Plant Extracts; Rabbits; Ramipril; Superoxide Dismutase; Time Factors; Triglycerides; Vitamin B Complex | 2010 |
Levosimendan suppresses oxidative injury, apoptotic signaling and mitochondrial degeneration in streptozotocin-induced diabetic cardiomyopathy.
Topics: Animals; Apoptosis; C-Reactive Protein; Cardiotonic Agents; Caspase 3; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Glutathione Peroxidase; Hydrazones; Hypoglycemic Agents; Insulin; Male; Malondialdehyde; Oxidative Stress; Pyridazines; Ramipril; Rats; Rats, Wistar; Simendan; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2016 |